LULIFOR
General Range

LULIFOR

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

LULIFOR Cream by Fortune Labs contains Luliconazole 1% w/w, a topical antifungal medicine used to treat various superficial fungal skin infections. Luliconazole works by inhibiting ergosterol synthesis, disrupting fungal cell membranes and helping control fungal growth. LULIFOR may be prescribed for ringworm, athlete's foot, and jock itch caused by susceptible fungi. It helps relieve associated symptoms such as itching, redness, and skin irritation as the infection improves. Available in convenient tube packaging, LULIFOR is part of Fortune Labs' dermatology product portfolio. Fortune Labs offers Derma PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, monopoly franchise opportunities, and business enquiries. Use externally as directed by a healthcare professional.

CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Luliconazole 1% w/w
Packaging Type
Laminated Tube with Outer Carton
Packaging Size
—
Dosage Form
Topical Antifungal Cream
Treatment
Fungal skin infections, ringworm (Tinea Corporis), athlete's foot (Tinea Pedis), jock itch (Tinea Cruris), itching, redness, and irritation associated
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana
View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?

More General Range

WhatsApp us